Loading
Latest filing published 28 Oct 2022 for GeneTether Therapeutics Inc., €665.
Roland Boivin discloses dealings in GeneTether Therapeutics Inc. to SEDI. The record holds 8 filings, for trades running from 21 March 2022 to 27 October 2022.
No open-market sale appears; the market trades are 5 purchases worth €2,242. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
In size, the median ticket on the buying side is €310.
On 28 October 2022 came the latest disclosure, an open-market purchase for €665 in GeneTether Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations